Clinical trials in St Germain En Laye – page 263

Investigating innovative combination therapies for follicular lymphoma, comparing mosunetuzumab plus lenalidomide against standard treatments to improve progression-free survival in previously untreated patients.

• Advanced lymphoma treatments
• Targeted therapy combinations
• Novel therapeutic approaches

Research focuses on enhancing treatment outcomes for high-risk lymphoma patients.

Evaluating treatment strategies for elderly women with HER2-negative breast cancer, examining the effectiveness of combined chemotherapy and hormone therapy based on genomic profiling.

• Age-specific treatment protocols
• Personalized therapy approaches
• Genomic-guided interventions

Studies aim to optimize treatment outcomes for senior patients while considering their specific needs.

Investigating treatment optimization for Secondary Progressive Multiple Sclerosis patients, focusing on the safety and efficacy of disease-modifying therapy withdrawal in stable patients over 50.

• Treatment discontinuation studies
• Age-specific MS management
• Long-term disease monitoring

Research aims to enhance quality of life while maintaining disease stability.

Examining preventive strategies for pregnancy-associated hypertension and pre-eclampsia through controlled trials of acetylsalicylic acid treatment in pregnant women with chronic hypertension.

• Maternal-fetal outcomes
• Preventive interventions
• Pregnancy complications

Focus on reducing maternal and fetal morbidity through preventive care.

Investigating the effects of preoperative cholecalciferol supplementation on post-thyroidectomy outcomes, specifically focusing on preventing hypocalcemia complications.

• Surgical outcome optimization
• Preventive supplementation
• Post-operative care

Research aims to improve patient recovery and reduce hospital stays after thyroid surgery.